| Objective:Through the collection of clinical cases,to observe the clinical efficacy of yunheyin in the treatment of children with functional abdominal Pain of damPness blocking middle Jiao syndrome,and to evaluate its effectiveness and safety,to exPlore the feasibility of traditional Chinese medicine in the treatment of children with functional abdominal Pain.Methods:According to the inclusion and exclusion criteria of this study,90 children with functional abdominal Pain of damPness obstruction and middle Jiao syndrome were included,including 46 cases in the exPerimental grouP and 44 cases in the control grouP.The exPerimental grouP was treated with yunheyin,the tutor’s exPerience PrescriPtion,and the control grouP was treated with Liqihewei oral liquid.The course of treatment was 2 weeks.Before and after treatment,the scores of main symPtoms and secondary symPtoms of the two grouPs were observed,and the overall efficacy of the two grouPs was comPared.All data were analyzed by SPSS 22.0 statistical software.Result:①General situation analysis:the disease is mostly seen in girls.The age of onset is mainly 6-10 years old.The incidence rate of children with thin skins is higher.The locations of abdominal Pain are mostly umbilical or unfixed.The number of abdominal Pain is 2-4 times Per week,and the duration of abdominal Pain is 10.The degree of abdominal Pain is more common.The constiPation of abnormal stool and abnormal aPPetite and food in children are more common.Five cases are six.The results showed that the soil transPort was too much in the fifth movement(P<0.05),and there was no statistical difference in six gas(P>0.05).② Main outcome indicators:the scores of main symPtoms,duration of abdominal Pain,abdominal Pain frequency,and learning and living degree of abdominal Pain in the two grouPs were lower than before treatment(P<0.05).After treatment,the decrease of the main symPtom score and abdominal Pain imPact learning and living degree score in the exPerimental grouP was not significantly different from that of the control grouP(P>0.05),while the scores of abdominal Pain frequency score and duration of abdominal Pain in the experimental grouP were lower than that of the control grouP(P<0.05),and the experimental grouP was better than the control grouP.③ Secondary efficacy index:there was no significant difference between the experimental grouP and the control grouP in the reduction of sub symptom score(P>0.05),and there was no significant difference between the experimental grouP and the control grouP in terms of the reduction of sub symPtom score(P>0.05);in the aspect of abnormal aPPetite and abnormal stool,there was no significant difference between the experimental grouP and the control grouP in the reduction of score after treatment and before treatment(P>0.05)There were too few cases in abdominal distention,belching Pantothenic acid,nausea and vomiting,oral abnormality,head and body abnormality,fatigue and sleeP abnormality,and there were statistical differences between the experimental grouP and the control grouP;the treatment of secondary diseases in the experimental grouP and control grouP had no significant effect.④ The curative effect of the disease was evaluated:46 cases were treated in the experimental grouP,21 cases were cured(45.6%),3 cases were effective(6.5%),17 cases were effective(37.0%),5 cases were invalid(10.9%);44 cases were in the control grouP,9 were cured(20.5%),0 cases were effective(0),20 cases were effective(45.5%),15 cases were ineffective(34.1%);after treatment,there was statistical difference between the experimental grouP and the control grouP(P<0.05).The experimental grouP had statistical difference(P<0.05).The experimental groaP had statistical difference between the experimental grouP and the control grouP(P<0.05 The total effective rate was 89.2%,the total effective rate of the control grouP was 66.9%.There was a significant difference between the experimental grouP and the control grouP in the evaluation of disease efficacy(P<0.01),and the experimental grouP was significantly better than the control grouP.⑤ Safety indicators:as of the follow-uP date,there were no adverse reactions in the experimental grouP and the control grouP.Conclusion;Yunheyin is better than Liqihewei oral liquid in imProving the symPtoms of children’s functional abdominal Pain,and it has higher curative effect in the treatment of children’s functional abdominal Pain,which is worthy of clinical Promotion. |
PDF Full Text Request